Replies to post #5881 on Galena Biopharma fka GALE

[Euripides90]

Up 4%, tired of this being seen as a "flipping stock" within a narrow range, we know current management is bending over backwards to avoid even the slightest perception of promotion but c'mom PPL, this is so under-valued/ oversold it's ridiculous!

Avg. analyst target = $5.25

http://www.earningswhispers.com/stocks.asp?symbol=GALE